Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scheme of Primary Prevention of Infection by COVID-19, in Workers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia

NCT04420260 is registered in ClinicalTrials.gov with Unidad de Investigación Genética Molecular as lead sponsor.

NCT NCT04420260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04420260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Scheme of Primary Prevention of Infection by COVID-19, in Workers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia
Lead sponsor
Unidad de Investigación Genética Molecular
Phase
Not applicable
Overall status
Completed
Start date
March 18, 2021
Completion date
July 5, 2021
Enrollment
152 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid